{"id":"W2947756907","doi":"10.1136/annrheumdis-2019-eular.1440","title":"SAT0393 EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; University of Ottawa; University of Toronto; Université de Montréal; University of Saskatchewan; Lakeridge Health; Nexus Clinical Research (Canada); Memorial University of Newfoundland","funders":"AstraZeneca; Amgen","keywords":"Medicine; Psoriatic arthritis; Ustekinumab; Golimumab; Internal medicine; Infliximab; Dactylitis; Population; Incidence (geometry); Enthesitis; Arthritis; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001704716,0.0003640293,0.001005697,0.000711993,0.0003983853,0.001190117,0.0005824799,0.0006082426,0.00191466],"category_scores_gemma":[0.002919785,0.0004018919,0.001875714,0.002249098,0.0003371329,0.0006734019,0.0004959028,0.0008574181,0.0004541176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004576572,"about_ca_system_score_gemma":0.0005437158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002611056,"about_ca_topic_score_gemma":0.002906952,"domain_scores_codex":[0.9978903,0.0006339837,0.0004319373,0.0004615101,0.0003554388,0.0002268361],"domain_scores_gemma":[0.9966663,0.0007207944,0.001529652,0.000460001,0.0003540311,0.0002692354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006302964,0.0001715301,0.9872937,0.00007134664,0.001312496,0.0001347566,0.00006478232,0.0001324331,0.0005587625,0.00004721274,0.0003382633,0.003571761],"study_design_scores_gemma":[0.0003542215,0.0008590805,0.9966236,0.00001627559,0.0008094136,0.0003300072,0.0001430803,0.0002595618,0.0001682379,0.00004033914,0.0003826176,0.00001356663],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997424,0.0007079637,0.00006737428,0.00003123305,0.00001228287,0.000009399845,0.001352627,0.000004479591,0.0003906018],"genre_scores_gemma":[0.9974902,0.0002389165,0.00006694366,0.00004828112,0.00002435621,0.00001543173,0.00201122,0.000003829401,0.0001008259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002611056,"threshold_uncertainty_score":0.00901556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01653192858621517,"score_gpt":0.2436608507875698,"score_spread":0.2271289222013546,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}